FDA announces recall of 2 different steerable guiding sheaths
Michael Walter | January 13, 2022 | Cardiovascular Business | Vascular & Endovascular
Product Recall

The FDA has announced that Oscor, a Florida-based healthcare technology company focused on cardiac care solutions, is recalling 14 lots of its Destino Twist 14F and Guidestar 14F steerable guiding sheaths.

The interventional devices, typically used for vascular procedures, have been found to have issues with the hub cap and seal on the proximal end of the handle detaching during use. The Destino Twist 14F and Guidestar 14F sheathes affected by this recall were distributed to customers and hospitals from June to November 2021.

“Oscor Inc. is notifying its distributors and customers by email and is arranging for the return of all recalled products,” according to the FDA advisory.

Click here for more information, including the exact model and lot numbers included in the recall.

Michael Walter
Michael Walter, Managing Editor

Michael has more than 16 years of experience as a professional writer and editor. He has written at length about cardiology, radiology, artificial intelligence and other key healthcare topics.

Related Content

Boston Scientific recalls premixed embolic agent after two deaths
Anemia may help explain why women are more likely to die during heart bypass surgery
FDA grants anticoagulant its orphan drug designation for treating patients with implanted devices
FDA announces new recall of neurovascular catheters built by Johnson & Johnson subsidiary
GE Healthcare launching new AI software for handheld ultrasound system
New study provides ‘substantial evidence’ paclitaxel-coated devices are safe when treating lower-limb PAD

Around the web

Health Imaging
New imaging protocols proposed to curb rise of cardiovascular infections

Eleven medical societies have signed on to a consensus statement aimed at standardizing imaging for suspected cardiovascular infections.

Radiology Business
What does radiology have to do with climate change?

Kate Hanneman, MD, explains why many vendors and hospitals want to lower radiology's impact on the environment. "Taking steps to reduce the carbon footprint in healthcare isn’t just an opportunity," she said. "It’s also a responsibility."

Radiology Business
Philips launches new AI-enabled CT scanner aimed at cardiology at ECR 2024

Philips introduced a new CT system at ECR aimed at the rapidly growing cardiac CT market, incorporating numerous AI features to optimize workflow and image quality.

Design by Adaptive Theme
Trimed Popup
Trimed Popup